National Cancer Center, Japan, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
National Cancer Centre Singapore, 11, Hospital Crescent, Singapore.
Asian Pac J Cancer Prev. 2020 May 1;21(5):1207-1212. doi: 10.31557/APJCP.2020.21.5.1207.
The socioeconomic burden of cancer is growing rapidly in the Asian region, with a concentrated burden on low- and middle- income countries. The residents of this region, representing almost 60% of the global population, demonstrate an eclectic and complex nature, with huge disparities in ethnicity, sociocultural practices among others. The Asian National Cancer Centers Alliance (ANCCA) was established in 2005 by heads of several national cancer centers (NCCs) in the region to address common issues and concerns among Asian countries. During the first 13 years of ANCCA's existence, the participating NCCs' senior managers paved the way toward collaboration through transparent sharing of key facts and activities. Concrete achievements of the Alliance include the Asia Tobacco-Free Declaration, the establishment of the ANCCA Constitution in 2014 as well as the creation of an official website more recently. In November 2019, the most active ANCCA members (China, India, Indonesia, Japan, Korea, Mongolia, Singapore, Thailand, and Vietnam) strengthened the bonds of the entity with the clear aim to halt the increase in cancer and mortality rates in Asian countries by 2030. New opportunities including accelerated cooperation between members as well as collaboration with external and multidisciplinary stakeholders at local, regional and international levels are an essential step to most effectively tackle cancers in Asia.
亚洲地区癌症的社会经济负担迅速增加,中低收入国家负担沉重。该地区的居民占全球人口的近 60%,他们的种族、社会文化习俗等差异巨大,具有折衷和复杂的特点。亚洲国家癌症中心联盟(ANCCA)于 2005 年由该地区几个国家癌症中心的负责人成立,旨在解决亚洲国家共同关心的问题。在 ANCCA 存在的前 13 年,参与的国家癌症中心的高级管理人员通过透明地分享关键事实和活动,为合作铺平了道路。该联盟的具体成就是发布了《亚洲烟草控制宣言》,2014 年制定了《ANCCA 章程》,最近还创建了一个官方网站。2019 年 11 月,最活跃的 ANCCA 成员(中国、印度、印度尼西亚、日本、韩国、蒙古、新加坡、泰国和越南)加强了该实体的联系,明确目标是到 2030 年遏制亚洲国家癌症发病率和死亡率的上升。包括成员之间加速合作以及与地方、区域和国际各级的外部和多学科利益攸关方合作在内的新机会,是在亚洲有效应对癌症的重要一步。